U2Bio Co (XKRX:221800) 5-Year ROIIC % : 369.21% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. U2Bio Co's 5-Year ROIIC % for the quarter that ended in Dec. 2023 was 369.21%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for U2Bio Co's 5-Year ROIIC % or its related term are showing as below:

XKRX:221800's 5-Year ROIIC % is ranked better than
94.29% of 210 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.89 vs XKRX:221800: 369.21

U2Bio Co 5-Year ROIIC % Historical Data

The historical data trend for U2Bio Co's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co 5-Year ROIIC % Chart

U2Bio Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

5-Year ROIIC %

Get a 7-Day Free Trial

48.47

443.46

-240.82

369.21

U2Bio Co Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
5-Year ROIIC %	-	-240.82	-	369.21

Competitive Comparison of U2Bio Co's 5-Year ROIIC %

For the Diagnostics & Research subindustry, U2Bio Co's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U2Bio Co's 5-Year ROIIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, U2Bio Co's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where U2Bio Co's 5-Year ROIIC % falls into.

U2Bio Co 5-Year ROIIC % Calculation

U2Bio Co's 5-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

5-Year ROIIC %	=	5-Year Incremental Net Operating Profit After Taxes (NOPAT)^**	/	5-Year Incremental Invested Capital^**
	=	( -22651.5524935 (Dec. 2023) - -687.9139632 (Dec. 2018) )	/	( 5861.033 (Dec. 2023) - 11809.777 (Dec. 2018) )
	=	-21963.6385303	/	-5948.744
	=	369.21%^***

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

U2Bio Co (XKRX:221800) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

U2Bio Co 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of U2Bio Co's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

U2Bio Co (XKRX:221800) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » 5-Year ROIIC %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Basement 1, 68 Gumaro Songpagu, Seoul, KOR

Website

http://www.u2bio.co.kr

U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines